177 related articles for article (PubMed ID: 8847038)
21. Lymphatic spread and microinvolvement in adenocarcinoma of the esophago-gastric junction.
Schurr PG; Yekebas EF; Kaifi JT; Lasch S; Strate T; Kutup A; Cataldegirmen G; Bubenheim M; Pantel K; Izbicki JR
J Surg Oncol; 2006 Sep; 94(4):307-15. PubMed ID: 16917878
[TBL] [Abstract][Full Text] [Related]
22. [Surgical treatment of gasto-esophageal junction adenocarcinoma: long-term results of a single Italian centre].
Pedrazzani C; Pasini F; Giacopuzzi S; Bernini M; Ruzzenente A; Festini M; Tomasi I; Cristadoro L; de Manzoni G
G Chir; 2004 Oct; 25(10):325-33. PubMed ID: 15756954
[TBL] [Abstract][Full Text] [Related]
23. Treatment results of adenocarcinoma of the gastroesophageal junction.
Yonemura Y; Kojima N; Kawamura T; Tsukiyama G; Bandou E; Sakamoto N; Tsubosa Y; Sato H
Hepatogastroenterology; 2008; 55(82-83):475-81. PubMed ID: 18613391
[TBL] [Abstract][Full Text] [Related]
24. Adenocarcinoma in the upper third part of the stomach.
Okamura T; Tsujitani S; Marin P; Haraguchi M; Korenaga D; Baba H; Sugimachi K
Surg Gynecol Obstet; 1987 Sep; 165(3):247-50. PubMed ID: 3629439
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and pathological prognostic factors for cancers of the esophagogastric junction].
Schmidt SC; Schlechtweg N; Veltzke-Schlieker W; Thuss-Patience P; Pratschke J; Neuhaus P; Schumacher G
Zentralbl Chir; 2009 Sep; 134(5):455-61. PubMed ID: 19757346
[TBL] [Abstract][Full Text] [Related]
26. Surgical outcome in patients with gastric adenocarcinoma in the upper third of the stomach.
Kunisaki C; Shimada H; Nomura M; Matsuda G; Otsuka Y; Ono H; Akiyama H
Surgery; 2005 Feb; 137(2):165-71. PubMed ID: 15674196
[TBL] [Abstract][Full Text] [Related]
27. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
[TBL] [Abstract][Full Text] [Related]
28. Adequacy of margins of resection in gastrectomy for cancer.
Bozzetti F; Bonfanti G; Bufalino R; Menotti V; Persano S; Andreola S; Doci R; Gennari L
Ann Surg; 1982 Dec; 196(6):685-90. PubMed ID: 7149820
[TBL] [Abstract][Full Text] [Related]
29. Is tumor size a prognostic indicator for gastric carcinoma?
Yokota T; Ishiyama S; Saito T; Teshima S; Yamada Y; Iwamoto K; Takahashi M; Murata K; Yamauchi H
Anticancer Res; 2002; 22(6B):3673-7. PubMed ID: 12552975
[TBL] [Abstract][Full Text] [Related]
30. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients.
Feith M; Stein HJ; Siewert JR
Surg Oncol Clin N Am; 2006 Oct; 15(4):751-64. PubMed ID: 17030271
[TBL] [Abstract][Full Text] [Related]
31. The extending range of the tumor is a more suitable predictive risk factor for lymph node metastases than the location of the deepest tumor invasion in distal thoracic esophageal and cardiac cancer.
Shiozaki A; Itoi H; Ueda Y; Sonoyama T; Yamagishi H
Oncol Rep; 2005 Jul; 14(1):195-9. PubMed ID: 15944789
[TBL] [Abstract][Full Text] [Related]
32. [The choice of surgical therapy in adenocarcinoma of the cardia].
Solerio D; Camandona M; Gasparri G; Casalegno PA; Raggio E; Dei Poli M
Minerva Chir; 2005 Feb; 60(1):17-22. PubMed ID: 15902049
[TBL] [Abstract][Full Text] [Related]
33. Tumor length as a prognostic factor in esophageal malignancy: univariate and multivariate survival analyses.
Griffiths EA; Brummell Z; Gorthi G; Pritchard SA; Welch IM
J Surg Oncol; 2006 Mar; 93(4):258-67. PubMed ID: 16496364
[TBL] [Abstract][Full Text] [Related]
34. E-cadherin expression as predictive marker of proximal resection line involvement for advanced carcinoma of the gastric cardia.
Polkowski WP; Skomra DG; Mielko J; Wallner GT; Szumiło J; Zinkiewicz K; Korobowicz EM; van Lanschot JJ
Eur J Surg Oncol; 2004 Dec; 30(10):1084-92. PubMed ID: 15522555
[TBL] [Abstract][Full Text] [Related]
35. [Infiltration length of gastric cancer on giant sections].
Xu DZ; Zhan YQ; Wu QL; Lai YR; Li W; Chen YB; Sun XW; Xu L; Guan YX; Li YF
Ai Zheng; 2005 Jun; 24(6):707-10. PubMed ID: 15946484
[TBL] [Abstract][Full Text] [Related]
36. Outcome of patients with cancer of the esophagogastric junction in relation to histology and surgical strategy.
Gianotti L; Braga M; Landoni L; Mari G; Scaltrini F; Di Castelnuovo A; Di Carlo V
Hepatogastroenterology; 2003; 50(54):1948-52. PubMed ID: 14696439
[TBL] [Abstract][Full Text] [Related]
37. Adenocarcinoma of the Esophagogastric Junction in China according to Siewert's classification.
Bai JG; Lv Y; Dang CX
Jpn J Clin Oncol; 2006 Jun; 36(6):364-7. PubMed ID: 16766566
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
39. Association of perioperative fluid balance and adverse surgical outcomes in esophageal cancer and esophagogastric junction cancer.
Wei S; Tian J; Song X; Chen Y
Ann Thorac Surg; 2008 Jul; 86(1):266-72. PubMed ID: 18573435
[TBL] [Abstract][Full Text] [Related]
40. Left thoracoabdominal approach for adenocarcinoma of the esophagogastric junction.
Nakamura T; Oguma H; Sasagawa T; Ota M; Kitamura Y; Yamamoto M
Hepatogastroenterology; 2008; 55(85):1332-7. PubMed ID: 18795683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
